Wells Fargo & Company Cuts Crescent Capital BDC (NASDAQ:CCAP) Price Target to $15.00

Crescent Capital BDC (NASDAQ:CCAP) had its target price reduced by investment analysts at Wells Fargo & Company from $16.00 to $15.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective would indicate a potential downside of 2.72% from the company’s current price.

Separately, Keefe, Bruyette & Woods cut Crescent Capital BDC from an “outperform” rating to a “market perform” rating and cut their target price for the stock from $18.50 to $17.00 in a research note on Friday. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, Crescent Capital BDC presently has an average rating of “Moderate Buy” and a consensus target price of $17.60.

Crescent Capital BDC Price Performance

Shares of Crescent Capital BDC stock opened at $15.42 on Friday. The business has a 50 day simple moving average of $16.19 and a two-hundred day simple moving average of $18.07. Crescent Capital BDC has a 12 month low of $13.54 and a 12 month high of $20.19. The stock has a market capitalization of $571.47 million, a P/E ratio of 7.75 and a beta of 0.63. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.32 and a quick ratio of 1.26.

Crescent Capital BDC (NASDAQ:CCAP) last posted its quarterly earnings results on Wednesday, May 14th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.52 by ($0.07). Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. The company had revenue of $42.13 million during the quarter, compared to analyst estimates of $45.08 million. As a group, analysts predict that Crescent Capital BDC will post 2.09 EPS for the current fiscal year.

Institutional Trading of Crescent Capital BDC

A number of hedge funds and other institutional investors have recently made changes to their positions in CCAP. Redhawk Wealth Advisors Inc. acquired a new stake in shares of Crescent Capital BDC during the fourth quarter worth about $659,000. Hennion & Walsh Asset Management Inc. increased its position in shares of Crescent Capital BDC by 11.9% during the fourth quarter. Hennion & Walsh Asset Management Inc. now owns 105,343 shares of the company’s stock worth $2,025,000 after purchasing an additional 11,161 shares in the last quarter. Van ECK Associates Corp increased its position in shares of Crescent Capital BDC by 2.3% during the fourth quarter. Van ECK Associates Corp now owns 45,562 shares of the company’s stock worth $876,000 after purchasing an additional 1,006 shares in the last quarter. Montag A & Associates Inc. acquired a new stake in shares of Crescent Capital BDC during the fourth quarter worth about $35,000. Finally, Ieq Capital LLC increased its position in shares of Crescent Capital BDC by 2.6% during the fourth quarter. Ieq Capital LLC now owns 22,725 shares of the company’s stock worth $437,000 after purchasing an additional 584 shares in the last quarter. Institutional investors and hedge funds own 49.46% of the company’s stock.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.